Skip to Content
Cancer Diagnosis Program
Contact NExT
Show menu
Search this site
Last Updated: 01/06/23

Complete List of Cancer Diagnosis Program Initiatives

The Requests for Applications (RFAs) and Program Announcements (PAs) listed below represent both expired and current Funding Opportunities from the Cancer Diagnosis Program and examples of the different type of funding mechanisms used by CDP. This table is intended to keep track of all CDP Funding Opportunities as well as serve as guidance for investigators seeking examples of previously funded projects by the Cancer Diagnosis Program

Date Mechanism Title Full Details Expiration Category
09/08/2022 R01 Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) PAR-22-243 9/08/2025 Bioengineering Technologies
09/08/2022 R01 Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed) PAR-22-242 9/08/2025 Bioengineering Technologies
07/14/2022 R21 NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) PAR-22-216 7/02/2025
01/21/2022 R01 Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) PAR-22-099 5/08/2025 Cancer TEC
10/22/2021 U01 Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) PAR-22-049 9/14/2024  
3/25/2021 R01 Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed) PAR-21-166 1/8/2024  
11/10/2020 R01 National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) PAR-21-033 1/8/2024  
10/13/2020 UH2 / UH3 Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) PAR-20-313 10/11/2023  
10/13/2020 UH3 Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) PAR-20-314 10/11/2023  
9/20/2020 R21 NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) PAR-20-292 7/21/2022  
12/10/2019 R01 Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed) PAR-20-074 10/29/2022  
8/28/2019 R21 NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) PAR-19-356 8/24/2020  
1/8/2019 R21 Exploratory/Developmental Bioengineering Research Grants(EBRG) (R21 Clinical Trial Not Allowed) PAR-19-149 1/8/2022 Bioengineering Technologies
1/8/2019 R21 Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) PAR-19-150 1/8/2022 Bioengineering Technologies
1/8/2019 R01 Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed) PAR-19-158 1/8/2022 Bioengineering Technologies
1/8/2019 R01 Bioengineering Research Grants (BRG) (R01 Clinical Trial Required) PAR-19-159 5/8/2022 Bioengineering Technologies
1/8/2019 U01 Bioengineering Research Partnerships (U01 Clinical Trial Not Allowed) PAR-19-156 1/8/2022 Bioengineering Technologies
1/8/2019 U01 Bioengineering Research Partnerships (U01 Clinical Trial Required) PAR-19-157 1/8/2022 Bioengineering Technologies
2/28/2018 R01 Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) PAR-18-530 3/25/2021  
1/5/2018 R01 National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) PAR-18-560 11/12/2020  
11/17/2017 R21 NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) PAR-18-020 3/23/2019  
11/13/2017 R21 Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) PA-18-286 1/8/2019 Bioengineering Technologies
11/7/2017 R01 Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) PAR-18-206 1/8/2019 Bioengineering Technologies
11/7/2017 U01 Bioengineering Research Partnerships (U01 Clinical Trial Optional) PAR-18-208 1/8/2019 Bioengineering Technologies
5/10/2016 R01 Bioengineering Research Grants (BRG) (R01) PAR-16-242 1/24/2018 Bioengineering Technologies
4/8/2016 R21 NCI Clinical and Translational Exploratory/Developmental Studies (R21) PAR-16-176 1/24/2018  
11/20/2015 R21 Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21)s PA-16-040 6/28/2018 Bioengineering Technologies
12/16/2016 U24 Cancer Immune Monitoring and Analysis Centers (CIMACs) RFA-CA-17-005 3/17/2017  
12/16/2016 U24 Cancer Immunologic Data Commons (CIDC) RFA-CA-17-006 3/17/2017  
10/4/2016 R01 Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants PAR-17-003 10/29/2019  
4/5/2016 U01 Integrating Biospecimen Science Approaches into Clinical Assay Development PAR-16-166 5/23/2018  
01/21/2015 UH2/UH3 — Exploratory/ Developmental Cooperative Agreement Phase I & Phase II Assay Validation For High Quality Markers For NCI-Supported Clinical Trials PAR-15-095 10/07/2017 Assay Development
01/21/2015 UH2/UH3 — Exploratory/ Developmental Cooperative Agreement Phase I & Phase II Assay Validation For High Quality Markers For NCI-Supported Clinical Trials PAR-15-096 10/07/2017 Assay Development
11/24/2014 UH2/UH3 — Exploratory/ Developmental Cooperative Agreement Phase I & Phase II Cancer Detection, Diagnosis, and Treatment Technologies for Global Health RFA-CA-15-001 03/07/2015 Global Health
06/05/2014 U24 — Resource-Related Research Project-Cooperative Agreement Limited Competition: Biospecimen Banks to Support NCI-Clinical Trials Network (NCTN) RFA-CA-14-501 08/16/2014 Biospecimen Resource
12/20/2013 R21 — NIH Exploratory/ Developmental Research Grant Award Early-Stage Innovative Molecular AnalysisTechnology Development for Cancer Research RFA-CA-14-003 (R21) 09/19/2014 Technology
Development
12/20/2013 R33 — NIH Exploratory/ Developmental Research Grant Award Phase II Validation and Advanced Development of  Emerging Molecular Analysis Technologies for Cancer Research RFA-CA-14-004  (R33) 09/19/2014 Technology
Development
12/20/2013 R21 — NIH Exploratory/ Developmental Research Grant Award Early-Stage Development of Innovative Technologies for Biospecimen Science RFA-CA-14-005 (R21) 09/19/2014 Technology
Development
12/20/2013 R33 — NIH Exploratory/ Developmental Research Grant Award Phase II Validation and Advanced Development of Emerging Technologies for Biospecimen Science RFA-CA-14-006 (R33) 09/19/2014 Technology
Development
10/30/2013 UH2/UH3 — Exploratory/ Developmental Cooperative Agreement Phase I & Phase II Cancer Detection, Diagnosis, and Treatment Technologies for Global Health RFA-CA-13-015 (UH2/UH3) 01/07/2014 Global Health
04/05/2013 R01 — NIH Research Project Grant Program Academic-Industrial Partnerships for Translation of in vivo Imaging Systems for Cancer Investigations PAR-13-169 (R01) 05/08/2016
03/19/2013 R21 — NIH Exploratory/ Developmental Research Grant Award NCI Exploratory/ Developmental Research Grant Program PAR-13-146  (R21) 09/05/2015 Exploratory Studies
02/21/2013 UM1 Multi-component Research Project – Cooperative Agreements Collaborative Human Tissue Network (CHTN) (UM1) RFA-CA-13-007 (UM1) 06/01/2013 Human Tissue Specimen Resources
12/21/2011 R21 — NIH Exploratory/ Developmental Research Grant Award Early-Stage Innovative Technology Development for Cancer Research RFA-CA-12-002 (R21) 09/19/2012 Technology
Development
12/21/2011 R33 — NIH Exploratory/ Developmental Research Grant Award Phase II Validation and Advanced Development of Emerging Technologies for Cancer Research RFA-CA-12-003 (R33) 09/19/2012 Technology
Development
11/16/2011 R01 — NIH Research Project Grant Program Validation of Molecular Diagnostics to Predict Patient Outcomes Using Specimens from Multi-Site Cancer Trials PA-12-013 (R01) 01/08/2015
11/16/2011 R21 — NIH Exploratory/ Developmental Research Grant Award Validation of Molecular Diagnostics to Predict Patient Outcomes Using Specimens from Multi-Site Cancer Trials PA-12-014 (R21) 01/08/2015
08/09/2011 R21 — NIH Exploratory/ Developmental Research Grant Award Pilot Studies in Pancreatic Cancer PA-11-297 (R21) 01/08/2015
08/09/2011 R03 — NIH Small Grant Program Pilot Studies in Pancreatic Cancer PA-11-298 (R03) 01/08/2015
09/29/2010 Request for Proposal (RFP) — Solicitation RECOVERY — Comprehensive Data Resource (CDR) RFP No. ST10-1124 10/27/2010 Biospecimen
Resource
09/01/2010 Request for Proposal (RFP) — Solicitation RECOVERY — Biospecimen Source Sites for Procurement of Cancer Biospecimens (formerly RFP No. ST10-1039) RFP No. ST10-1105 10/12/2010 Biospecimen
Resource
07/21/2010 R01 — NIH Research Project Grant Program Bioengineering Research Partnerships (BRP) PAR-10-234 (R01) 01/08/2014 Technology
Development
04/06/2010 R41/R42 — NIH Small Business Technology Transfer (STTR) Grants Phase I & II Bioengineering Nanotechnology Initiative PA-10-149 (STTR — R41/R42) 05/08/2013 Technology
Development
04/06/2010 R43/R44 — NIH Small Business Technology Transfer (SBIR) Grants Phase I & II Bioengineering Nanotechnology Initiative PA-10-150 (SBIR — R43/R44) 05/08/2013 Technology
Development
03/18/2010 Request for Proposal (RFP) — Solicitation RECOVERY — Comprehensive Biospecimen Resource RFP No. ST10-1035 06/17/2010 Biospecimen
Resource
11/17/2009 U24 — Resource-Related Research Project — Cooperative Agreement Limited Competition: Support for Human Specimen Banking in NCI-Supported Clinical Trials — Cooperative Group Banks (CGB) (U24) RFA-CA-09-504 03/31/2015 Biospecimen
Resource
11/16/2009 Request for Proposal (RFP) — Solicitation caHUB Acquisition of Normal Tissues RFP No. S10-084 03/12/2010 Biospecimen
Resource
11/16/2009 R21 — NIH Exploratory/ Developmental Research Grant Award Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis PA-10-026 (R21) 01/08/2013 Exploratory Studies
Clinical Correlative Studies
11/16/2009 R01 — NIH Research Project Grant Program Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis  PA-10-025 (R01) 01/08/2016 Clinical Correlative Studies
11/03/2009 Request for Proposal (RFP) – Solicitation RECOVERY: R&D on Human Biospecimen Integrity RFP No. ST10-1005 12/14/2009 Biospecimen Research
10/14/2009 R01 — NIH Research Project Grant Program Bioengineering Research Grants (BRG) PA-10-009 (R01) 03/11/2013 Technology
Development
10/14/2009 R21 — NIH Exploratory/ Developmental Research Grant Award Exploratory/ Developmental Bioengineering Research Grants (EBRG) PA-10-010 (R21) 01/08/2013 Technology
Development
10/14/2009 R21 — NIH Exploratory/ Developmental Research Grant Award Exploratory/ Developmental Bioengineering Research Grants (EBRG) PA-12-284 (R21) 01/08/2016 Technology
Development
10/14/2009 R01 — NIH Research Project Grant Program Bioengineering Research Grants (BRG) PAR-13-137 (R01) 05/08/2016 Technology
Development
07/22/2009 R21 — NIH Exploratory/ Developmental Research Grant Award Exfoliated Cells and Circulating DNA in Cancer Detection and Diagnosis PA-09-238 (R21) 09/08/2012 Technology Development
Clinical Correlative Studies
06/01/2009 R21 — NIH Exploratory/ Developmental Research Grant Award Identifying Non-coding RNA Targets for Cancer Early Detection and Prevention PA-09-200 (R21) 09/08/2012 Exploratory Studies
05/05/2009 Request for Proposal (RFP) – Solicitation Biospecimen Contributing Institutions for Research Studies in Cancer Tissue Pre-Analytical Variables RFP No. S09-148 06/18/2009 Biospecimen Research
04/17/2009 R03 — NIH Small Grant Program Developmental Projects in Complementary Approaches to Cancer Care and Treatment PA-09-168 (R03) 05/08/2012 Exploratory Studies
04/14/2009 R21 — NIH Exploratory/ Developmental Research Grant Award Developmental Research in Cancer Prognosis and Prediction PA-09-158 (R21) 05/08/2012 Exploratory Studies
Technology Development
04/14/2009 R33 — NIH Exploratory/ Developmental Research Grant Award Phase II Developmental Research in Cancer Prognosis and Prediction PA-09-159 (R33) 05/08/2012 Technology
Development
04/14/2009 R21 — NIH Exploratory/ Developmental Research Grant Award Developmental Research in Cancer Prognosis and Prediction PA-09-158 (R21) 05/08/2012 Clinical Correlative Studies
04/14/2009 R33 — NIH Exploratory/ Developmental Research Grant Award Phase II Developmental Research in Cancer Prognosis and Prediction PA-09-159 (R33) 05/08/2012 Clinical Correlative Studies
10/01/2008 Request for Proposal (RFP) – Solicitation R&D on Human Biospecimen Integrity RFP No. S08-280 12/09/2008 Biospecimen Research
09/23/2008 R21 — NIH Exploratory/ Developmental Research Grant Award Exploratory Studies in Cancer Detection, Diagnosis and Prognosis PA-08-267 (R21) 09/08/2012 Exploratory Studies
Technology Development
07/18/2008 R21 — NIH Exploratory/ Developmental Research Grant Award Pilot Studies in Pancreatic Cancer PA-08-208 (R21) 09/08/2011 Exploratory Studies
Clinical Correlative Studies
07/18/2008 R03 — NIH Small Grant Program Pilot Studies in Pancreatic Cancer PA-08-209 (R03) 09/08/2011 Exploratory Studies
Clinical Correlative Studies
04/22/2008 R01 — NIH Research Project Grant Program Biomarkers of Infection-Associated Cancers PA-08-156 (R01) 05/08/2011 Clinical Correlative Studies
04/22/2008 R21 — NIH Exploratory/ Developmental Research Grant Award Biomarkers of Infection-Associated Cancers PA-08-157 (R21) 05/08/2011 Clinical Correlative Studies
04/22/2008 R01 — NIH Research Project Grant Program Biomarkers of Infection-Associated Cancers PA-11-158 (R01) 05/08/2014
04/22/2008 R21 — NIH Exploratory/ Developmental Research Grant Award Biomarkers of Infection-Associated Cancers PA-11-159 (R21) 05/08/2014
04/11/2008 R21 — NIH Exploratory/ Developmental Research Grant Award Mitochondria in Cancer Epidemiology, Detection, Diagnosis and Prognosis PA-08-144 (R21) 05/08/2011 Exploratory Studies
04/11/2008 R01 — NIH Research Project Grant Program Mitochondria in Cancer Epidemiology, Detection, Diagnosis and Prognosis PA-08-143 (R01) 05/08/2011 Clinical Correlative Studies
04/04/2008 R01 — NIH Research Project Grant Program Correlative Studies with Specimens from Multi-Site Trials PA-08-134 (R01) 11/18/2011 Clinical Correlative Studies
04/04/2008 R21 — NIH Exploratory/ Developmental Research Grant Award Correlative Studies with Specimens from Multi-Site Trials PA-08-133 (R21) 05/08/2011 Clinical Correlative Studies
11/19/2007 R21 — NIH Exploratory/ Developmental Research Grant Award Quick-Trials for Novel Cancer Therapies and Prevention: Exploratory Grants PAR-08-025 (R21) 11/10/2010 Clinical Correlative Studies
01/04/2007 R21 — NIH Exploratory/ Developmental Research Grant Award Innovations In Cancer Sample Preparation RFA-CA-07-037 (R21) 09/28/2007 Technology
Development
01/04/2007 R33 — NIH Exploratory/ Developmental Research Grant Award Phase II Innovations In Cancer Sample Preparation RFA-CA-07-038 (R33) 09/28/2007 Technology
Development
01/04/2007 R43/R44 — NIH Small Business Technology Transfer (SBIR) Grants Phase I & II Innovative Technologies for Molecular Analysis of Cancer RFA-CA-07-039 (SBIR — R43/R44) 09/29/2007 Small Business
01/04/2007 R41/R42 — NIH Small Business Technology Transfer (STTR) Grants Phase I & II Innovative Technologies for Molecular Analysis of Cancer RFA-CA-07-040 (STTR — R41/R42) 09/29/2007 Small Business
01/04/2007 R43/R44 — NIH Small Business Technology Transfer (SBIR) Grants Phase I & II Application of Emerging Technology For Cancer Research RFA-CA-07-041 (SBIR — R43/R44) 09/29/2007 Small Business
01/04/2007 R41/R42 — NIH Small Business Technology Transfer (STTR) Grants Phase I & II Application of Emerging Technology For Cancer Research RFA-CA-07-042 (STTR — R41/R42) 09/29/2007 Small Business
01/04/2007 R43/R44 — NIH Small Business Technology Transfer (SBIR) Grants Phase I & II Innovations In Cancer Sample Preparation RFA-CA-07-043 (SBIR — R43/R44) 09/29/2007 Small Business
01/04/2007 R41/R42 — NIH Small Business Technology Transfer (STTR) Grants Phase I & II Innovations In Cancer Sample Preparation RFA-CA-07-044 (STTR — R41/R42) 09/29/2007 Small Business
04/27/2006 R21 — NIH Exploratory/ Developmental Research Grant Award In Vivo Cancer Imaging Exploratory/ Developmental Grants PA-06-371 (R21) 05/08/2009 Exploratory Studies